BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Llewellyn GN, Seclén E, Wietgrefe S, Liu S, Chateau M, Pei H, Perkey K, Marsden MD, Hinkley SJ, Paschon DE, Holmes MC, Zack JA, Louie SG, Haase AT, Cannon PM. Humanized Mouse Model of HIV-1 Latency with Enrichment of Latent Virus in PD-1+ and TIGIT+ CD4 T Cells. J Virol 2019;93:e02086-18. [PMID: 30842333 DOI: 10.1128/JVI.02086-18] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang W, Zhou M, Chen C, Wu S, Wang L, Xia B, Liu J, Ma X, Pan T, Zhang H, Li L, Liu B. Identification of CD98 as a Novel Biomarker for HIV-1 Permissiveness and Latent Infection. mBio 2022;13:e0249622. [PMID: 36214569 DOI: 10.1128/mbio.02496-22] [Reference Citation Analysis]
2 Ollerton MT, Folkvord JM, Peachman KK, Shashikumar S, Morrison EB, Jagodzinski LL, Peel SA, Khreiss M, D'Aquila RT, Casares S, Rao M, Connick E. HIV-1 infected humanized DRAGA mice develop HIV-specific antibodies despite lack of canonical germinal centers in secondary lymphoid tissues. Front Immunol 2022;13:1047277. [PMID: 36505432 DOI: 10.3389/fimmu.2022.1047277] [Reference Citation Analysis]
3 Rodríguez-Izquierdo I, Sepúlveda-Crespo D, Lasso JM, Resino S, Muñoz-Fernández MÁ. Baseline and time-updated factors in preclinical development of anionic dendrimers as successful anti-HIV-1 vaginal microbicides. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2022;14:e1774. [PMID: 35018739 DOI: 10.1002/wnan.1774] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Sun Y, Xue J. Expression Profile and Biological Role of Immune Checkpoints in Disease Progression of HIV/SIV Infection. Viruses 2022;14:581. [DOI: 10.3390/v14030581] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Di Y, Lavender KJ. Inducing Long-Term HIV-1 Latency in the TKO-BLT Mouse Model. Methods in Molecular Biology 2022. [DOI: 10.1007/978-1-0716-1871-4_18] [Reference Citation Analysis]
6 Peng X, Tao R, Chen Y, Su J, Huang Y, Zhu B. Transient HIV Reservoirs and Interleukin-6 Increase After Anti-Programmed Death-1 Antibody Infusion in HIV Patients with Lung Cancer. JIR 2022;Volume 15:199-204. [DOI: 10.2147/jir.s349099] [Reference Citation Analysis]
7 Edwards VL, Mccomb E, Gleghorn JP, Forney L, Bavoil PM, Ravel J. Three-dimensional models of the cervicovaginal epithelia to study host-microbiome interactions and sexually transmitted infections.. [DOI: 10.1101/2021.11.04.467382] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Dash PK, Gorantla S, Poluektova L, Hasan M, Waight E, Zhang C, Markovic M, Edagwa B, Machhi J, Olson KE, Wang X, Mosley RL, Kevadiya B, Gendelman HE. Humanized Mice for Infectious and Neurodegenerative disorders. Retrovirology 2021;18:13. [PMID: 34090462 DOI: 10.1186/s12977-021-00557-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Terahara K, Iwabuchi R, Tsunetsugu-Yokota Y. Perspectives on Non-BLT Humanized Mouse Models for Studying HIV Pathogenesis and Therapy. Viruses 2021;13:776. [PMID: 33924786 DOI: 10.3390/v13050776] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Abeynaike S, Paust S. Humanized Mice for the Evaluation of Novel HIV-1 Therapies. Front Immunol 2021;12:636775. [PMID: 33868262 DOI: 10.3389/fimmu.2021.636775] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Marsden MD, Zhang TH, Du Y, Dimapasoc M, Soliman MSA, Wu X, Kim JT, Shimizu A, Schrier A, Wender PA, Sun R, Zack JA. Tracking HIV Rebound following Latency Reversal Using Barcoded HIV. Cell Rep Med 2020;1:100162. [PMID: 33377133 DOI: 10.1016/j.xcrm.2020.100162] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
12 Adams P, Fievez V, Schober R, Amand M, Iserentant G, Rutsaert S, Dessilly G, Vanham G, Hedin F, Cosma A, Moutschen M, Vandekerckhove L, Seguin-Devaux C. CD32+CD4+ memory T cells are enriched for total HIV-1 DNA in tissues from humanized mice. iScience 2021;24:101881. [PMID: 33364576 DOI: 10.1016/j.isci.2020.101881] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
13 Cai H, Liu G, Zhong J, Zheng K, Xiao H, Li C, Song X, Li Y, Xu C, Wu H, He Z, Zhu Q. Immune Checkpoints in Viral Infections. Viruses 2020;12:E1051. [PMID: 32967229 DOI: 10.3390/v12091051] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
14 Vendrame E, Seiler C, Ranganath T, Zhao NQ, Vergara R, Alary M, Labbé AC, Guédou F, Poudrier J, Holmes S, Roger M, Blish CA. TIGIT is upregulated by HIV-1 infection and marks a highly functional adaptive and mature subset of natural killer cells. AIDS 2020;34:801-13. [PMID: 32028328 DOI: 10.1097/QAD.0000000000002488] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 9.7] [Reference Citation Analysis]